In rosacea patients, the increased levels of IL-6 correlate with ROS production and activation of the hypoxia-induced factor HIF-1α [59,62], and both effects are mediated through the IL-6/JAK/STAT3 pathway [63,64]. Here, IL6 is linked to rosacea.